Download presentation
1
Renaissance Computing Institute (RENCI)
VisualDecisionLinc A Comparative Effectiveness Approach To Advance Decision Support in Psychiatry Ketan K. Mane Renaissance Computing Institute (RENCI) 14th March 2011
2
Members RENCI Duke University Kenneth Gersing (Psychiatry Dept.)
Ketan K. Mane Charles Schmitt Chris Bizon Phil Owen Duke University Kenneth Gersing (Psychiatry Dept.) Bruce Burchett Ricardo Pietrobon
3
Healthcare Cost - Overview
US health delivery cost Current: ~$8,000 per capita, ~$2.4 trillion (16.4% of GDP) 2015 Projection: ~$11,000 per capita, ~18.4 of GDP Psychiatric study for year 2000 reveals – 16% of MDD patients in US population Cost ~$84 billion Factors contributing to healthcare cost include – Ineffective initial treatment (dose iteration) Medication error Adverse events due to medication switching Or Relapse US healthcare - Most advanced … but cost paid is too high … numbers Moore’s Law Informatics perspective on the factor we can take care of …. that contribute to the cost of health care involve – Ineffective initial treatment … the amt of titration phase involved …. To get to the dosage that would work is trial and error Strong consensus among experts exist that decision support tools that aid clinicians decision making process hold tremendous potential to improve clinical care and reduce cost
4
Electronic Medical Record Systems (EMRs)
EMRs – store massive amount of patient data including treatment and outcomes Stored data offers great potential to improve quality and care through evidence based medicine approach Ability to determine best treatment options for patient at the point of care is a critical component of patient quality care Optimal treatment strategies strained by – Reduced clinician time per patient Information overload - search for data of interest takes time EMR data – treatment and outcomes related data Embedded knowledge about … what works for what patients and under what circumstances Essentially …. The evidence to practice evidence-based medicine EHRs data is likely to improve quality, if the evidence is available at the point of care. Health IT provides access – but data not in readily interpretable format ….Tabular format Large data results and basic result presentation formats, the complexity of data interpretation also increases with data size. Volume of data – 5 min Dr. Time - Information overload – Need for external aid to make sense of data Big constraints in EMR data usage
5
Similar based on medical profile
Comparative Effectiveness Research (CER) Comparative Effectiveness Research Goal Approaches to help identify best treatment choices for the patient EMR data: Patient Diagnosis + Treatment + Outcomes EMR Patient Similar based on medical profile Promising approach to use of EMR data …. Is CER CER – offers to build treatment options with patient centric view EMR data available – but Therapeutic choices are widely unclear (What works best for whom, when, and in what circumstances)
6
Comparative Effectiveness for Decision Support
Comparative Effectiveness Research (CER) Comparative Effectiveness Research Goal Approaches to help identify best treatment choices for the patient EMR data: Patient Diagnosis + Treatment + Outcomes Advantages of Comparative Effectiveness Research Approach Personalized Medicine - patient’s medical profile based treatment Speed treatment delivery at the point of care Help investigate effects at the sub-group levels (e.g. the elderly, racial and ethnic minorities) Accelerate translation of new discoveries into practice for better outcomes Comparative Effectiveness for Decision Support (offers potential to bridge the gap between evidence and clinical practice) CER as DS .. Aligns with the Evidence-based Medicine principle … way to bridge gap …. And help identify right treatment to the right patient at the right time CER – data driven approach
7
Clinical Guidelines Define treatment plan to be followed by clinicians
Formed by expert committees (informed through clinical trials) Non-adherence to guidelines among clinicians Clinician’s use clinical protocols/guidelines for decision support. Protocols encapsulates the best treatment related evidence for patients in different stages in their treatment. Build by experts – with informed knowledge gathered from clinical trials Non-adherence … These guidelines are built from clinical trials by using controlled population in a closely monitored clinical setting. bcos in the real world setting, there exists very little overlap in the conditions that were used in the clinical trials to build the protocols. Not updated Lack of specificity But guidelines do incorporate the best of the decision point … an capture the expert view …. So can we leverage of that information And use it in conjunction with EMR data which defines the real world population …. To gather insight Use of EMR data as supplement information with guideline – offers potential to use data to create personalized treatment profile plan 7
8
Clinical Guidelines and CER Approach
What works and what doesn't? ‘Clinical Trials’ – determine comparative effectiveness Clinical trials Next best thing? – EMR data Expensive Cheap Slow Fast Controlled population Real-world population Current Setup Data Collection Clinical Care /EMR Warehouse So … based on the previous slides, we know that …. CER based data driven approach and protocol based approach offer insight into what works and what doesn’t Traditionally, we know … clinical trials are the way to determine CER Alternatively, we can use EMR data … to passively collect the information …. And use it with the protocols Current setup – no knowledge readily available at the point of care…. Thus overview of the motivation is – How can we make meaningful use of the massive amt of EMR patient related data And present it to the clinicians in a format that is meaningful, Or facilitates their decision making process … at the point of care… What is the best way to understand the CER … and use it to identify what works and what doesn’t How can one best leverage of the decision points available in protocols/clinical guidelines … Research Knowledge 8
9
MindLinc: EMR Largest de-identified psychiatry outcome data warehouse (110,000 patients or 2,400,000 clinical encounters over a 10 year span) Widely distributed across 25 US institutions academic institutions (25%), community mental health centers (50%) private practice, hospitals, other combined (25%) Sample data for initial analysis: ~30,000 visits of patients with Major Depressive Disorder (MDD) All Patients (N = ) Demographics Primary Diagnosis Child 14809 Additional 9582 Adolescent 13804 Adjustment 11114 Adult 70028 Anxiety 10427 Senior 11294 Bipolar 9189 Childhood 10484 Cognitive 8881 Gender Depression 20462 Male 50217 Dissociative 54 Female 59163 Eating 1452 Factitious 26 Race GMC 223 Black 19714 Impulse Control 1314 White 44923 Mood 6038 Other 12115 1856 Race unknown 33250 Personality 791 Psychotic 5511 Schizophrenia 3150 Sexual 130 Sleep 704 Somatoform 494 Substance 9649 Table 1: Characteristics of patients in MindLinc
10
Analytics Identify set of attributes that are clinically relevant to define the comparative population Approach would help define attributes that – Makes patients similar to one another Help extract meaningful patient’s features (if any) to determine treatments Identify statistically important attributes that define differences in outcomes
11
Requirements of a Decision Support Tool
Part of the workflow - quick and easy to use Helps reduce information overload Provides a good overview of evidence (comparative population) Support clinician’s decision making process Interactive and provides clinician with control to filter data based on their needs Provides additional insights The emerging field of Visual Analytics is focusing on combining related research areas such as visualization, data analytics to handle large and heterogeneous volumes of data, such as EHR. Visual Analytic Approach – away to address the above needs, and to facilitate the decision making capability at the point of care, dynamic in nature 11
12
VisualDecisionLinc: Dashboard for Clinical Decision Support
1 4 2 3 5 6 7 8 1 Patient demographics 3 Comorbid conditions 5 Patient Treatment Response 71 Prescribed Rx info 2 Response to Rx 4 Guideline view 6 Projected Response to Rx 8 Patient visit type info
13
VisualDecisionLinc – at the Point of Care
Outbound EMR – Codified De-identification of Local Data Interface to Centralized Warehouse Centralized Data Warehouse Data Analysis – Statistician Expert Consensus Data Warehouse + Clinical Trials Inbound Codification of Rules for export Interface - Transfer rules to local systems Decision Support Patient Profile + Business Rules Contextual Presented at point of decision Visualization of Data
14
Information Flow in VisualDecisionLinc
15
Clinical Guideline So far …. We covered how the CER can be presented to the user … for them to interact with it … and narrow it down to the comp population Of their interest … to make facilitate their decision making process … Now, onto the guideline piece …to use the guideline as template to view patient information
16
Clinical Guideline – Prior Approach
Guideline Element Model (GEM) GLIDES Guidelines – scope restricted to recommendations (alerts, reminders on screening, etc.) SEBASTIAN system from Duke University – leading the effort to define the national standards toward HL-7 in decision support XML representation of guidelines
17
Clinical Guideline – Our Approach
18
Clinical Guideline – Our Approach
emphasize heavily at this point that we are looking at various approaches and would welcome feedback and thoughts on best approaches.
19
VisualDecisionLinc - Next Steps
Integrate it with the MindLinc EMR Incremental deployment to get feedback from clinicians Explore alternate approaches to map patient data to clinical guidelines/protocols. UI level - effectiveness study (NSF proposal submitted with Dr. Javed Mostafa) Explore potential other domain where can apply this approach where dataset is readily available
20
Summary of the Talk Decision Support Space
Changing focus of Health IT – to make sense from EMR data Comparative Effectiveness Research Approach – offers potential to bridge the gap between evidence and clinical practice VisualDecisionLinc: Visual Analytics + CER approach Novel way to look at patient data and the comparative data at the same time Interactive Dashboard – ad hoc define and customize comparative population Clinical Guideline - New approach to view patient data in the context of the clinical guideline Visual Analytics for Decision Support Approach has the potential to serve as a template that can be extended to other medical conditions
21
Questions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.